Literature DB >> 22405559

Whole parasite vaccination approaches for prevention of malaria infection.

Noah S Butler1, Ashley M Vaughan, John T Harty, Stefan H I Kappe.   

Abstract

Malaria is caused by complex protozoan Plasmodium parasites that have foiled efforts to develop a protective vaccine. Despite this, it has been known for more than 40 years that immunization with radiation-attenuated, whole Plasmodium sporozoites confers complete protection against malaria challenge. This model gave the rationale for development of recombinant and vectored subunit vaccination strategies that have, however, not yet matched whole sporozoite protective efficacy. Novel attenuation and immunization approaches for whole sporozoite vaccination and a deeper understanding of cellular and humoral protective immune responses that eliminate pre-erythrocytic stages are paving the way for the development of next-generation vaccination strategies that completely prevent malaria.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22405559     DOI: 10.1016/j.it.2012.02.001

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  35 in total

1.  Artesunate versus chloroquine infection-treatment-vaccination defines stage-specific immune responses associated with prolonged sterile protection against both pre-erythrocytic and erythrocytic Plasmodium yoelii infection.

Authors:  Xiaohong Peng; Gladys J Keitany; Marissa Vignali; Lin Chen; Claire Gibson; Kimberly Choi; Fusheng Huang; Ruobing Wang
Journal:  J Immunol       Date:  2014-06-23       Impact factor: 5.422

2.  Protective Efficacy Induced by Genetically Attenuated Mid-to-Late Liver-Stage Arresting Plasmodium berghei Δmrp2 Parasites.

Authors:  Maarten van der Velden; Sanna R Rijpma; Vivienne Verweij; Geert-Jan van Gemert; Séverine Chevalley-Maurel; Marga van de Vegte-Bolmer; Blandine M Franke-Fayard; Frans G M Russel; Chris J Janse; Robert W Sauerwein; Jan B Koenderink
Journal:  Am J Trop Med Hyg       Date:  2016-06-13       Impact factor: 2.345

Review 3.  An expanding toolkit for preclinical pre-erythrocytic malaria vaccine development: bridging traditional mouse malaria models and human trials.

Authors:  Ryan Wj Steel; Stefan Hi Kappe; Brandon K Sack
Journal:  Future Microbiol       Date:  2016-11-18       Impact factor: 3.165

4.  CD8 T cell independent immunity after single dose infection-treatment-vaccination (ITV) against Plasmodium yoelii.

Authors:  Katherine L Doll; Noah S Butler; John T Harty
Journal:  Vaccine       Date:  2013-12-07       Impact factor: 3.641

5.  Immunization with genetically attenuated P. falciparum parasites induces long-lived antibodies that efficiently block hepatocyte invasion by sporozoites.

Authors:  Olivia C Finney; Gladys J Keitany; Hannah Smithers; Alexis Kaushansky; Stefan Kappe; Ruobing Wang
Journal:  Vaccine       Date:  2014-02-28       Impact factor: 3.641

6.  A T-cell response to a liver-stage Plasmodium antigen is not boosted by repeated sporozoite immunizations.

Authors:  Sean C Murphy; Arnold Kas; Brad C Stone; Michael J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

7.  An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection.

Authors:  Tuan M Tran; Shanping Li; Safiatou Doumbo; Didier Doumtabe; Chiung-Yu Huang; Seydou Dia; Aboudramane Bathily; Jules Sangala; Younoussou Kone; Abdrahamane Traore; Moussa Niangaly; Charles Dara; Kassoum Kayentao; Aissata Ongoiba; Ogobara K Doumbo; Boubacar Traore; Peter D Crompton
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

8.  Type II fatty acid biosynthesis is essential for Plasmodium falciparum sporozoite development in the midgut of Anopheles mosquitoes.

Authors:  Ben C L van Schaijk; T R Santha Kumar; Martijn W Vos; Adam Richman; Geert-Jan van Gemert; Tao Li; Abraham G Eappen; Kim C Williamson; Belinda J Morahan; Matt Fishbaugher; Mark Kennedy; Nelly Camargo; Shahid M Khan; Chris J Janse; Kim Lee Sim; Stephen L Hoffman; Stefan H I Kappe; Robert W Sauerwein; David A Fidock; Ashley M Vaughan
Journal:  Eukaryot Cell       Date:  2013-12-02

9.  Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity.

Authors:  Else M Bijker; Guido J H Bastiaens; Anne C Teirlinck; Geert-Jan van Gemert; Wouter Graumans; Marga van de Vegte-Bolmer; Rianne Siebelink-Stoter; Theo Arens; Karina Teelen; Wiebke Nahrendorf; Edmond J Remarque; Will Roeffen; Annemieke Jansens; Dunja Zimmerman; Martijn Vos; Ben C L van Schaijk; Jorien Wiersma; André J A M van der Ven; Quirijn de Mast; Lisette van Lieshout; Jaco J Verweij; Cornelus C Hermsen; Anja Scholzen; Robert W Sauerwein
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-18       Impact factor: 11.205

10.  A Plasmodium yoelii Mei2-Like RNA Binding Protein Is Essential for Completion of Liver Stage Schizogony.

Authors:  Dorender A Dankwa; Marshall J Davis; Stefan H I Kappe; Ashley M Vaughan
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.